China’s NMPA Considers Breakthrough Designations for Xiangxue and Innostellar’s Therapies
Xiangxue Pharmaceutical Co., Ltd (SHE: 300147) and Innostellar Biotherapeutics Co., Ltd have both been noted...
Athenex
Athenex Sells China Subsidiaries to TiHe Capital for USD 19 Million
US-based Athenex Inc. (Nasdaq: ATNX) announced an agreement to sell all equity interests in its...